Zinc supplementation in pre-diabetes: study protocol for a randomized controlled trial

Trials

Priyadarshani Galappaththy²  Godwin R Constantine¹  Prasad Katulanda¹  ASAD Pigera²  Ranil Jayawardena³  Priyanga Ranasinghe² 

[1] Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka;Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka;Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia

关键词: Adults;    Sri Lanka;    Pre-diabetes;    Zinc supplementation;   

Others  :  1094712
DOI  :  10.1186/1745-6215-14-52

 received in 2012-11-20, accepted in 2013-02-04,  发布年份 2013

【 摘 要 】

Background

The number of people with diabetes is increasing worldwide, especially in developing South Asian countries. Therefore, preventing diabetes at the early stages has become an important issue. Recent clinical trials, systematic reviews, and meta-analysis have shown that zinc has beneficial effects on glycemic and metabolic control in those with diabetes. The present study is designed to evaluate the effects of zinc supplementation on glycemic control and other metabolic parameters in those with pre-diabetes.

Methods/design

The study will be conducted as a randomized, double-blind, placebo-controlled clinical trial for a period of 12 months at the Faculty of Medicine, University of Colombo, Sri Lanka. The study has been approved by the Ethics Review Committee of Faculty of Medicine, University of Colombo (EC/11/189). A total of 200 adults (age 18–60 years) with pre-diabetes will be recruited for the study. They will be stratified according to age, gender, and body mass index and randomly assigned into the test and placebo groups on a 1:1 ratio. The zinc capsules, each weighing 456 mg, will contain the following ingredients:zinc sulfate monohydrate 55.096 mg (elemental zinc 20 mg), lactose monohydrate 399.504 mg, and stearic acid 1.400 mg. The placebo capsule with the same weight will be comprised of lactose monohydrate 454.600 mg and stearic acid 1.400 mg. The subjects will receive either zinc 20 mg capsules or placebo daily for a period of 12 months. The study drugs will be double blinded to both investigators and subjects. The visits and the evaluations will be done as follows: screening (visit 0), 1 month (visit 1), 3 month (visit 2), 6 month (visit 3), and 12 month (visit 4). The following primary outcome measures will be evaluated:fasting plasma glucose (FPG), post oral glucose tolerance test (OGTT), serum insulin, HbA1c, total/low-density lipoprotein (LDL)/high-density lipoprotein (HDL) cholesterol, triglycerides, serum zinc, and appetite using a visual analog scale. Secondary outcome measures include: blood pressure, anthropometry, and dietary assessment using a validated food frequency questionnaire. Data will be analyzed using SPSS v16.

Discussion

The present protocol will aim to establish the beneficial effects of zinc supplementation on disease progression in those with pre-diabetes and also establish its effectiveness in the prevention of diabetes mellitus.

Trial registration

Sri Lanka Clinical Trial Registry: SLCTR/2012/010

【 授权许可】

   
2013 Ranasinghe et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP: Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health 2012, 12:380. BioMed Central Full Text
• [2]Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH, Matthews DR: The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. DiabetolMetabSyndr 2012, 4(1):21.
• [3]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
• [4]Katulanda P, Sheriff MH, Matthews DR: The diabetes epidemic in Sri Lanka—a growing problem. Ceylon Med J 2006, 51(1):26-28.
• [5]Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka–Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med 2008, 25(9):1062-1069.
• [6]Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH: The direct medical cost of type 2 diabetes. Diabetes Care 2003, 26(8):2300-2304.
• [7]Zalewski PD, Millard SH, Forbes IJ, Kapaniris O, Slavotinek A, Betts WH, Ward AD, Lincoln SF, Mahadevan I: Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc. J HistochemCytochem 1994, 42(7):877-884.
• [8]Chausmer AB: Zinc, insulin and diabetes. J Am CollNutr 1998, 17(2):109-115.
• [9]Kelly F: Use of antioxidants in the prevention and treatment of disease. J Int Fed ClinChem 1998, 10(1):21-23.
• [10]Simon SF, Taylor CG: Dietary zinc supplementation attenuates hyperglycemia in db/db mice. ExpBiol Med (Maywood) 2001, 226(1):43-51.
• [11]Oh HM, Yoon JS: Glycemic control of type 2 diabetic patients after short-term zinc supplementation. Nutr Res Pract 2008, 2(4):283-288.
• [12]Al-Maroof RA, Al-Sharbatti SS: Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J 2006, 27(3):344-350.
• [13]Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S: Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes MetabSyndrObes 2011, 4:53-60.
• [14]Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P: Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. DiabetolMetabSyndr 2012, 4(1):13.
• [15]Hashemipour M, Kelishadi R, Shapouri J, Sarrafzadegan N, Amini M, Tavakoli N, Movahedian-Attar A, Mirmoghtadaee P, Poursafa P: Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens) 2009, 8(4):279-285.
• [16]World Health Organization, International Diabetes Federation: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
• [17]Jayawardena R, Swaminathan S, Byrne NM, Soares MJ, Katulanda P, Hills AP: Development of a food frequency questionnaire for Sri Lankan adults. Nutr J 2012, 11(1):63. BioMed Central Full Text
• [18]Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zincexternal link icon. Washington DC: Institute of Medicine Food and Nutrition Board; 2001.
• [19]Mantzoros CS, Prasad AS, Beck FW, Grabowski S, Kaplan J, Adair C, Brewer GJ: Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 1998, 17(3):270-275.